To investigate the role of mast cells in the development of summer-type hypersensitivity pneumonitis (SHP), which is the most commontype of hypersensitivity pneumonitis in Japan, bronchoalveolar lavage fluid (BALF) cells from 13 patients with this disease was studied by light and electron microscopy. The proportion and number of BALFmast cells recovered from SHP patients were significantly greater than those from patients with sarcoidosis and from control subjects. The BALFmast cells from the SHPpatients showed various ultrastructural changes such as the transformation of granules, cytoplasmic vacuolation, and an increase of lipid droplets. These findings appeared to reflect activation and degranulation of bronchoalveolar mast cells, suggesting that mast cells play a role as inflammatory cells in the development of SHP.
Introduction
Summer-type hypersensitivity pneumonitis (SHP) is the most commonhypersensitivity pneumonitis (HP) in Japan, and is caused by the inhalation of molds in the homeenvironment during the hot and humid summer ( 1) . A causative agent of the disease is thought to be Trichosporon cutaneum, an imperfect yeast (2) .
Bronchoalveolar lavage (BAL) has revealed many characteristic aspects of HP, and is an essential diagnostic procedure for this disease. Recently, several reports (3-6) have mentioned that mast cells are present in increased numbers in the bronchoalveolar lavage fluid (BALF) of patients with HP such as farmer's lung or bird fancier's lung. Thus, a role of mast cells in the development of HPhas been suggested. Although many BALstudies have also been reported for SHP, few of them have discussed BALFmast cells.
In the present study, we determined the number of mast cells in the BALFof patients with SHPand observed their ultrastructure by transmission electron microscopy (TEM) in order to investigate whether mast cells play a role in the inflammatory process of SHP.
Materials and Methods

Subjects
Thirteen patients (3 menand 10 women), whowere diagnosed as having SHP at Kurashiki Central Hospital between September 1988 and September 1993, were evaluated. Their mean age was 46.3 year (range; 19-69 year). Two ofthepatients were smokers, and three had a history of SHPrecurrence for more than two years. The diagnosis of SHPwas based on the following criteria prepared by the research committee organized by the Japanese Ministry of Welfare in 1980 (1): [1] clinical features and laboratory findings including chest X-ray which are compatible with HP, [2] Nine men and 3 women(8 smokers and 4 nonsmokers) who had normal radiological findings but underwent bronchoscopy for suspected bronchial carcinoma (confirmed in 2 patients) served as control subjects. Theirmean age was 6 1.3 year (range; 34-84 year). As a disease control, BAL samples from 18 patients with sarcoidosis (6 men and 12 women)were studied. Their mean age was 45.1 year (range; 27-75 year) and there were 4 smokers and 14 nonsmokers. Prior to the present study, the protocol was approved by the institutional ethics committee and informed consent was obtained from all subjects after full explanation of the procedures involved.
BALprocedure BALwas performed using a standard procedure (7). Days from admission to lavage ranged from 1 to 19. Patients were premedicated with opium alkaloids, atropine sulphate, and hydroxidine. After topical anesthesia of the larynx and trachea, a fiberoptic bronchoscope (Olympus Type 1T20, Olympus Co. , Tokyo, Japan) was introduced and wedged into a subsegmental bronchus of the right middle lobe or left lingular lobe. Aliquots (50 ml x 3) of normal saline were infused, and the fluid was withdrawn manually into syringes. The BALFwas strained through a monolayer of surgical gauze to remove mucus, collected in a siliconized glass vessel cooled on ice, and transported immediately to the laboratory.
Light microscopy ofBALF The total cell count of the recovered BALFwas determined by counting the cells in a resuspended salt solution. Cytocentrifuge preparations were produced and stained with MayGriinwald-Giemsa stain. Then the differential cell count was determined by examining at least 1,000 cells, and was expressed as a percentage of the total number of cells present. For detecting mast cells, the preparations were also stained with acid toluidine blue stain. Then 5,000 cells per slide were scanned, and the cells with characteristic metachromatic granules were identified as mast cells. The numberof mast cells per milliliter and the percentage of mast cells in the total lavage cells were determined.
Electron microscopic processing BALFsamples recovered from the patients with SHPexcept for cases 1 and 3 were also subjected to electron microscopic examination. Lavage fluid was centrifuged at 750 g for 10 minutes, and cell pellets were fixed in 2% paraformaldehyde mixed with 1 %glutaraldehyde, washed in phosphate-buffered saline, post-fixed in 1%osmiumtetroxide, and embedded in Spurr resin. Ultrathin sections werethen cut on a microtome (MT-6000, RMC Co., Texas, USA) with a diamond knife, doubly stained with uranyl acetate and lead citrate, and examined under a transmission electron microscope (H-600 Hitachi Co., Tokyo, Japan) to observe ultrastructure of mast cells. The BALFfrom one control subject was also examined electron microscopically to determine the normal ultrastructural features of the mast cells.
Photographic prints of mast cells from three SHP patients (cases 4, 6 and 7) in whose BALFwe could detect more than eight mast cells were prepared at a standard magnification of x 1 2,000. Photoprints of five mast cells from the control subject were also prepared. The secretory granules of each cell were counted differentially under the headings of 1) scroll, 2) particulate, and 3) empty types, and were expressed as a mean percentage per mast cell. All counts were performed by one observer (T.I.)-
Statistical methods
For statistical analysis, we used the Kruskal-Wallis test for comparisons between the groups and a p value of <0.05 was 
Results
Numbers of mast cells in the BALF
The total number of BALFcells and the differential cell counts in the patients with SHPare summarized in Table 2 . The median values in BALFcells from the sarcoidosis patients and the control subjects were also listed. All the patients with SHP revealed a marked increase in the percentage of lymphocytes and a reciprocal decrease in macrophages in the BALF. The median percentage of mast cells in the patients with SHP was 0.39% (range; 0.19%-0.93%), and this was significantly higher than those from the control subjects (range; 0%-0. 16%, p<0.0001) and from the sarcoidosis patients (range; 0%-0.2%, p<0.0001). The median absolute number of mast cells was 1.7xlO3/ml (range; 0.6-ll.2xlO3/ml) in the SHP group, and this was also significantly increased when compared with the control subjects (range; 0-0.8xl03/ml, p<0.0001) and the sarcoidosis patients (range; 0-0.6x103/ml, p<0.0001) (Fig. 1) . The relationship between the proportion or number of mast cells and clinical parameters including arterial oxygen pressure (PaO2), vital capacity (VC), and carbon monoxide diffusing capacity (Dlco) were also studied in SHPpatients. However, no significant correlation could be found between them.
Ultrastructuralfeatures ofBALFmast cells Electron microscopic observation confirmed the presence of mast cells and not basophils in the BALF. The typical ultrastructural features of a mast cell were seen in the BALFfrom the control subject including a single round nucleus, surface projections, and cytoplasmic granules (Fig. 2) . The granules were electron-dense and measured 600 nm to 800 nm in diameter. At a higher magnification, most of these granules revealed a characteristic dense scroll form (Fig. 2) . Granules varied from crystalloid to cylindrical according to the plane of sectioning. Granules with forms other than scroll one accounted SHP: summer-type hypersensitivity pneumonitis. for only few percent of all the granules (Table 3 ). BALFmast cells from the patients with SHPshowed various ultrastructural changes. They demonstrated fewer granules than the normal controls, marked cytoplasmic vacuolation, and other features suggestive of activation including prominent surface projections and an increase of lipid droplets (Fig. 3) . The most prominent change compared with the control mast cells was in the morphologyof the granules, since there were fewer scroll granules and those with a particulate form were increased (Fig. 3) . As is listed in Table 3 , granules with particulate form accounted for 40 to 50%of all the granules.
The contents of some granules was released, and fusion of membranesbetween adjacent granules was also observed (Fig.   4 ).
Discussion
SHPis one type of HPwhich occurs under special environmental conditions. Most patients develop symptomssuch as fever, cough, and dyspnea at homein the summerseason. The inhaled antigen which causes SHPis thought to be Trichosporon cutaneumbecause serum antibodies to this yeast are detected in most patients with this disease (2) . Ando et al (8) surveyed 835 cases of HP in Japan, and reported that 621 (74.4%) were proved to be SHP. Thus, SHP is the mostcommon type of HP in Japan, especially in the western and southern parts of the country where it is very humid in summer. Somereports about pulmonary mast cells in HPhave been published recently. In 1987, Soler et al (3) reported that the number of mast cells recovered by BALfrom patients with HP was more than 1,000 times greater than that recovered from normal individuals. In addition, discontinuation of antigen exposure resulted in an increase of mast cells, while other inflammatory cells such as neutrophils and eosinophils showed a rapid decrease. Haslam et al (4) also reported that patients with farmer's lung and bird fancier's lung showed a greater increase of BALFmast cells than patients with other types of interstitial pneumonitis, and that the mast cells revealed features suggestive of activation on electron microscopy. Bjermer et al (5) studied BALFobtained in the acute phase offarmer's lung, and demonstrated a relationship between bronchoalveolar mastocytosis and disease activity. In 1991, Pesci et al (6) observed that mast cells were increased in BALFand in transbronchial biopsy specimens obtained from patients with farmer's lung, and suggested that mast cells seemed to be primary inflammatory cells involved in HPalong with lymphocytes. Prior to these reports, Kawanami et al (9) from 1 8 patients with chronic stage HP, and observed numerous mast cells in the edematous interstitium. In 1989, Takizawa et al ( 10) published a suggestive study on mast cell-deficient mice. These mice did not develop severe HP-like lesions despite repeated transnasal administration of antigens. However, after bonemarrow-derivedmast cells weretransferred to the mice, HP-like lesions were enhancedjust like in normal mice. These results suggested that mast cells play an important role in the development of experimental HP. Manystudies have investigated the features of BALFin patients with SHP. However,most of them concentrated on the lymphocytesor neutrophils, and little attention waspaid to mast cells. In the present study, we used acid toluidine blue staining and transmission electron microscopy (TEM) to detect BALF mast cells. Acid toluidine blue produced metachromatic staining of mast cell granules, and made it easy to distinguish the mast cells from other cells, while observation on TEMcould confirm the presence of mast cells even when they were completely degranulated.
In BALFobtained from SHPpatients, mast cells shared a significant increase in both absolute numbers and percentage when compared with the control subjects and the disease controls with sarcoidosis, another granulomatous lung disease. However, the percentage of mast cells in our SHPpatients was no more than 0.5 to 1.0%, and was muchlower than reported in patients with farmer's lung and bird fancier's lung. This may be due to a difference in disease activity between different varieties of HP. SHPoccurs in the home environment, and the patients are usually exposed to a small antigen load over a long period.
Thus, the onset of symptoms and signs of the patients are generally milder than in other types of HPand the moderate increase of mast cells seemsto reflect this reduced disease activity. The degree ofmastcytosis in our SHP patients showed no correlation with clinical parameters. Thus, analyses of many more HP patients will be necessary in order to prove a relationship between BALmastcytosis and disease activity. Ultrastructurally, the mast cells showedvarious changes such as cytoplasmic vacuolation, increased lipid droplets and morphological changes of the granules. These findings suggested that activation and degranulation of mast cells occurred in the SHP lung. Especially, the transformation of granules was prominent. Both percentages of granules with paniculate form and empty granules were much higher in SHP patients than in the control subject, though we did not undertake a statistical analysis due to the small number of mast cells detected in BALF from the control. Haslamet al (4) also studied the morphology of mast cell granules in BALFfrom patients with farmer's lung and bird fancier's lung, and reported that most cells had granules with particulate and empty forms. Mast cells are knownto be heterogeneous and to reveal different morphological and biochemical features according to the site and disease condition. Ultrastructural studies have
shownthat the structure of mast cell granules varies from mixed to particulate in morphology along with a degranulation gradient (1 1). Kawanami (12) observed the differences of mast cell degranulation between interstitial lung fibrosis and allergic lung disease using TEM.In chronic interstitial disease, the granules showed gradual substructural modification including scroll, crystal, particulate, and fine filamentous elements , which were considered to reflect a process of slow degranulation. On the other hand, particulate granules were predominant in bronchial asthma and HP, and adjacent granules fused to form labyrinthine structures, findings which were considered to reflect rapid degranulation. The mast cells of our SHPpatients showed a predominance of particulate granules, and the fusion of granular membranes, but no labyrinth formation, so this was considered to be an intermediate type ofdegranulation. Someof our patients revealed mild symptoms, and three patients had a history of recurrence. The decreased disease activity may be . Histamine is known to injure endothelial cells and to stimulate fibroblast proliferation (15). Mastcells also release various vasoactive mediators which cause a delayed hypersensitivity reaction and produce further tissue damage. There have also been more reports (16-18) of an increase of mast cells in patients with pulmonary fibrosis. It was further reported that mast cells are increased in lung tissue of sarcoidosis patients (16). However, the subjects examinedin that report were in the fibrotic stage and in morean advanced state of sarcoidosis than the present patients. Taking these findings into consideration, the mast cell maybe one of the initiators of inflammation in interstitial lung diseases including HP, although whether this process is primary or secondary to the pathogenesis remains unclear. Further studies, including biochemical and ultrastructural investigations, are needed to confirm the role of mast cells in HPand to establish the pathological mechanisms causing granulomatous lung disease.
